In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. - Wikidata - wikimedia - TriplyDB

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

http://www.wikidata.org/entity/Q34547502

about

Multi-tissue DNA methylation age predictor in mouse.Role of p16INK4a and BMI-1 in oxidative stress-induced premature senescence in human dental pulp stem cells.Theory and associated phenomenology for intrinsic mortality arising from natural selection Cocktail of chemical compounds robustly promoting cell reprogramming protects liver against acute injury High-Definition Medicine.Rejuvenating Strategies for Stem Cell-Based Therapies in Aging.Mitochondrial Dynamics: In Cell Reprogramming as It Is in Cancer.Therapeutic potential of systemic brain rejuvenation strategies for neurodegenerative disease.Senescence-Inflammatory Regulation of Reparative Cellular Reprogramming in Aging and Cancer.Transient transcription factor (OSKM) expression is key towards clinical translation of in vivo cell reprogramming Maintenance and repair of an aging life cycle.TOR-mediated regulation of metabolism in aging.Fleeting factors, turning back time.Gathering by the Red Sea highlights links between environment and epigenetics.Septic Shock and the Aging Process: A Molecular Comparison.The interplay between epigenetic changes and the p53 protein in stem cells.The Potential of iPSCs for the Treatment of Premature Aging Disorders.Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins.Short-term Low-Dose mTORC1 Inhibition in Aged Rats Counter-Regulates Age-Related Gene Changes and Blocks Age-Related Kidney Pathology.Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.Cardiac rejuvenation: a new hope in the presbycardia nightmare.Stem Cell Transplantation for Frailty.Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases.Cardiac and systemic rejuvenation after cardiosphere-derived cell therapy in senescent rats.Mechanisms underlying longevity: A genetic switch model of aging.Neural stem cells: developmental mechanisms and disease modeling.Aging and the Krüppel-like factors.Modeling the Role of Wnt Signaling in Human and Drosophila Stem Cells.Elixir of Life: Thwarting Aging With Regenerative Reprogramming.Epigenetic regulation of cell fate reprogramming in aging and disease: A predictive computational model.DeepSimulator: a deep simulator for Nanopore sequencing.Epigenetic Mechanisms Impacting Aging: A Focus on Histone Levels and Telomeres.Chemical compound-based direct reprogramming for future clinical applications.An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome.Implications of Cellular Aging in Cardiac Reprogramming.In vivo reprogramming drives Kras-induced cancer development.Methionine Restriction Extends Lifespan in Progeroid Mice and Alters Lipid and Bile Acid Metabolism AAVvector-mediated in vivo reprogramming into pluripotency FoxM1 repression during human aging leads to mitotic decline and aneuploidy-driven full senescence FACT Sets a Barrier for Cell Fate Reprogramming in Caenorhabditis elegans and Human Cells

P2860

Q33556578-3C9E89DF-EE5D-4242-A71D-3A580CE4578D Q33561584-057AD5F4-11E0-4F50-B432-A10D6CE0360C Q36326935-CED3A189-8433-4C19-B89F-174936722E87 Q37712423-93662149-03F0-47B2-AC88-95580F3369E2 Q38608277-577E93E9-8CAD-4209-806F-22CAB62F71E1 Q38981139-2B5F2528-0649-4213-B61E-3CB074FF0446 Q39292567-E5B5FB47-A851-4C44-B13A-F90B4B066483 Q41208095-4984C39F-9EEA-46A4-A034-E7EBAC6504BC Q42121084-0FF3BF22-553F-4C04-AE1A-08D5F4DB74D0 Q42233597-E13E7098-A6DD-4C42-9D12-218891776C79 Q45341729-D3F539E4-EE4F-4B32-BE84-374E6A8C203D Q45863420-D0EF4B6C-DBFD-4D93-9D46-78C39E44365F Q46314960-92905A47-9E97-49C1-9308-23B861D13B51 Q46391170-E0003C37-0E21-43E3-ABCC-059EB8E00FA3 Q47094206-0BE2487D-323C-45AB-B1FB-3A0621E047AD Q47101729-03E7A7DF-E809-476E-B1B5-4797AA556657 Q47105441-8658F6B2-D93E-4D87-94F7-70E89B8D410D Q47119516-048A2EE0-2EA8-4A02-A142-2B75C70BAA05 Q47229701-B78A0795-ADDD-4A44-8501-3E7C06A8F00A Q47414799-CB8E43E0-AEA1-4281-BC76-884489D0B692 Q47567405-0C5B39BD-C4F1-4C0F-9FDD-DF9B160AE862 Q47740786-07E032D1-A2D9-4DA6-9D24-B80F8661FE72 Q47974120-C276585C-5F9F-4C9E-A94F-B546C05F0C14 Q48024280-F8DEBF5C-5DFD-4572-8CE2-66D8D57A5694 Q48158774-CD3570F6-0D20-4C95-B1C4-367760664CAF Q49353189-25FAB402-541F-4F0F-BC98-7BB47AE74EA4 Q49372792-1F9401E3-CC32-4D7A-A636-8BEBC39FD9AA Q49805610-4ACD9A73-2875-4FB6-A4BC-E982B52ED2EE Q50187342-8C6A669B-E476-462B-8334-C34B73048019 Q51556720-D43349C9-8385-4C7E-9A10-5423AA3B6A17 Q52320373-26FB093E-1351-4C19-8F1A-939E54019592 Q52324791-98F3265A-EEE6-416E-AB24-8E0689565869 Q54217784-0A7EF171-0A82-4449-94EB-FC0DB1D0C037 Q55004770-4DBAFCCB-719E-4F0F-B746-F9E9281F9C3E Q55005606-EF5A2C95-698E-455B-81DD-A1DB6423DAF1 Q55252335-C41553A5-5E99-476C-8826-CE28CF4784DB Q57110712-6B1BA50E-56C8-44ED-A5CB-A958E0EFB9C7 Q57562597-CCE94516-D176-43FC-A866-D83ECA6080B1 Q58319815-4443B7E5-CE1B-44D1-B497-A91D0C402215 Q58754595-FC6913A6-BA75-4636-A909-DF374720842C

P2860

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

http://www.wikidata.org/entity/Q34547502

description

2016 nî lūn-bûn

@nan

2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

@ast

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

@en

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

@nl

type

label

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

@ast

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

@en

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

@nl

prefLabel

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

@ast

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

@en

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

@nl

P1433

Q34547502-FA0A29EC-1101-4C86-BA62-80E9F7DFA2D4

P1476

Q34547502-24D188A0-B28A-4FAF-AF9F-E5BCEFC82E45

P2093

Q34547502-04482672-3603-41A3-81D1-585D8B8D042C

Q34547502-0C12F9E7-3084-46B4-BF7E-74F4805AEB02

Q34547502-16AF5D9C-9994-4CB0-B40B-C19F1607706B

Q34547502-31A69381-9003-45B3-AF3A-EF55E9F1D597

Q34547502-3844C5E6-A2EC-45C4-B652-D056BEEDBF01

Q34547502-39C30F64-1BBB-48EE-B461-487445144097

Q34547502-42B4BC3D-B2D9-422E-8545-90ACF4A3766D

Q34547502-4F2D2364-4114-4F54-92BE-8BDEB525B7EB

Q34547502-617455AD-8A36-4E48-AF35-98674F0192D7

Q34547502-6BB3A187-C132-46B8-9C47-FD45595C3630

P2860

Q34547502-025C6197-310A-4CBC-8253-1E0748BA9605

Q34547502-041086E3-C252-404C-ADE0-87B87AE72C09

Q34547502-1B09E845-AFCC-48EA-88A4-95CC59D762CE

Q34547502-1BEB547C-B2C5-4CD7-BFF5-F3337EF90B21

Q34547502-1DB18466-213E-4209-A40A-2043D4F269B5

Q34547502-1FFC6C6E-DF63-456A-A63A-41B24329F5E3

Q34547502-20F704C6-B7CF-4B10-979A-BA55DA331FFD

Q34547502-222B13CF-9F2D-4418-BB22-E0A83A2CA4B3

Q34547502-25D95EB7-71E7-4F22-8D94-9A475553EE81

Q34547502-2638E9F4-3261-41EB-8AD7-AB165858B20F

P304

Q34547502-F98C6346-B526-4164-A9E7-FC1F0F8987F9

P31

Q34547502-5F42DA0A-488C-4613-A97D-338443E7A92E

P356

Q34547502-7D8FAC44-5EEA-45E7-95D9-0F7C075242E6

P407

Q34547502-8F03C983-3542-4462-A72A-01C702FB6D4B

P433

Q34547502-54F95E64-C220-4257-8D1B-E82B5E980D6A

P478

Q34547502-67B0EB4C-2CF1-4BF2-A076-09BAEBA5F97E

P50

Q34547502-0836B04B-2B40-42E6-BB15-D67AFE03E8E1

Q34547502-5E2F47FD-C8C3-4B1F-ABD6-43F45E2E04A8

Q34547502-7DACB4D8-97FD-4353-95E3-0C5F70634A65

Q34547502-7E476C0A-9746-4DDD-B3FD-EC8682B47C4A

P577

Q34547502-CB2037CD-5285-49CB-A1CF-6CFB1FB06B62

P698

Q34547502-C56A4249-BCDB-43A3-9CC1-087AC1C54CAE

P932

Q34547502-F7D22421-F74E-43D5-ABA9-708D6EDCD208

P356

J.CELL.2016.11.052

P1433

P1476

In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.

@en

P2093

Alejandro Ocampo

http://www.w3.org/2001/XMLSchema#string

Concepcion Rodriguez Esteban

http://www.w3.org/2001/XMLSchema#string

David Donoso

http://www.w3.org/2001/XMLSchema#string

David Lam

http://www.w3.org/2001/XMLSchema#string

Ergin Beyret

http://www.w3.org/2001/XMLSchema#string

Eric Vazquez-Ferrer

http://www.w3.org/2001/XMLSchema#string

Estrella Nuñez Delicado

http://www.w3.org/2001/XMLSchema#string

Fumiyuki Hatanaka

http://www.w3.org/2001/XMLSchema#string

Gabriel Nuñez

http://www.w3.org/2001/XMLSchema#string

Isabel Guillen

http://www.w3.org/2001/XMLSchema#string

P2860

Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome

mTOR is a key modulator of ageing and age-related disease

Lamin A-dependent nuclear defects in human aging

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

The hallmarks of aging

Sarcopenia: causes, consequences, and preventions

Genomic instability in laminopathy-based premature aging

The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging

Maintenance of muscle stem-cell quiescence by microRNA-489

The genetics of ageing

P304

1719-1733.e12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELL.2016.11.052

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P50

Aida Platero-Luengo

Masakazu Kurita

Paloma Martínez-Redondo

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27984723

http://www.w3.org/2001/XMLSchema#string

P932

5679279

http://www.w3.org/2001/XMLSchema#string